Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Small molecule Lck inhibitors promote long-term allograft survival

May 24, 2004

Novel CCR5 antagonists for transplant rejection, autoimmune diseases, etc.

May 21, 2004

Phase II/III trial of AIC for treatment of ragweed allergy now fully enrolled

May 21, 2004

Isotechnika receives clearance to initiate phase I trial of TAFA-93 in Canada

May 21, 2004

Largest-ever trial begins to evaluate efficacy and safety of IGIV for CIDP

May 20, 2004

3M scientists develop immune response modifiers for use in viral infections and cancer

May 14, 2004

CTA submitted for Canadian phase I trials of TAFA-93

May 12, 2004

Biovitrum and Symphogen enter recombinant polyclonal antibody collaboration

May 12, 2004

NIH licenses rotavirus vaccine to BIOVIRx

May 11, 2004

New immunosuppressant agents covered by Kyorin patent

May 10, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....